All day long, our brains carry out complicated and energy-intensive tasks such as remembering, solving problems, and making decisions.

Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 7,175 calls trading, 1.0x expected, and implied vol increasing almost 2 ...

Since 2020, Chart Industries has pivoted toward expanding its specialty portfolio of products into high-growth areas such as hydrogen and liquefied natural gas. It made several attractive ...

The all-stock merger between Chart and Flowserve triggered a sell-off, despite the deal's strategic appeal. Read more on GTLS and FLS stocks here.

Industrial companies Chart Industries Inc. and Flowserve Corp. agreed to merge in a deal valuing the combined company at about $19 billion.

(Reuters) -U.S.-based equipment manufacturer Chart Industries and flow control systems maker Flowserve Corp agreed to merge in an all-stock deal, valuing the combined company at about $19 billion. The ...

Meanwhile, it's already finding success with AI-enabled patient portals – and ambient scribing is showing big promise too. The Baltimore health system's digital health physician leader explains.

Is your feature request related to a problem? Please describe. Diagnostics are emitted for all recursive functions inside of library shaders, when they should only be emitted for functions that are ...

AI Biotech Recursion Commits $88M to a Pair of Drug Discovery Acquisitions Recursion Pharmaceuticals is acquiring two Canada-based artificial intelligence startups, Cyclica and Valence.